中华脑科疾病与康复杂志(电子版) 2016年6月,6卷3期

综述

脓毒症和脓毒症相关性脑病

周业庭1 王光胜2 王少丹3 童道明2

223600 江苏省沭阳县人民医院普外科1,神经内科2,重症监护科3
童道明;Email:tongdaoming@163.com

摘要:脓毒症定义为宿主对感染的反应失调引起的威胁生命的器官功能障碍,分为全身炎症反应综合征(SIRS)阳性和阴性两个类型。脓毒症仍是全球广泛流行的危重症之一,大约70%的脓毒症可能诱发一种脓毒症相关性脑病,病死率高达51.0%~71.9%。脓毒症和脓毒症相关性脑病常复杂多变,诊断困难。临床上,采用SIRS-阳性和SIRS-阴性脓毒症分类诊断标准,可减少脓毒症和脓毒症相关性脑病的漏诊。

关键词:脓毒症; 全身炎症反应综合征; 诊断; 预后; 脓毒症相关性脑病

江苏省临床重点专科建设项目(20160017)

参考文献

1 Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM Consensus Conference Committee.American College of Chest Physicians/Society of Critical Care Medicine[J].Chest, 1992,101(6):1644-1655.
2 Levy MM,Fink MP,Marshall JC,et al.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J].Crit Care Med,2003,31(4):1250-1256.
3 Shankar-Hari M,Phillips GS,Levy ML,et al.Developing a New Definition and Assessing New Clinical Criteria for Septic Shock:For the Third International Consensus Definitions for Sepsis and Septic Shock(Sepsis-3)[J].JAMA, 2016,315(8):775-787.
4 Leonid AE,Debby P,Chaim P,et al.The spectrum of septic encephalopathy definitions,etiologies,and mortalities[J].JAMA,1996,275(6):470-473.
5 Wilson JX,Young GB.Progress in clinical neurosciences:sepsis-associated encephalopathy:evolving concepts[J].Can J Neurol Sci,2003,30(2):98-105.
6 Rangel-Frausto MS,Pittet D,Costigan M,et al.The natural history of the systemic inflammatory response syndrome(SIRS):a prospective study [J].JAMA,1995,273(2):117-123.
7 Kaukonen KM,Bailey M,Pilcher D,et al.Systemic inflammatory response syndrome criteria in defining severe sepsis[J].N Engl J Med,2015,372(17):1629-1638.
8 Angus DC,Linde-Zwirble WT,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care[J].Crit Care Med,2001,29(7):1303-1310.
9 Bolton CF,Young GB,Zochodne DW.The neurological complications of sepsis[J].Ann Neurol,1993,33(1):94-100.
10 Mascia L,Sakr Y,Pasero D,et al.Extracranial complications in patients with acute brain injury:a post-hoc analysis of the SOAP study[J].Intensive Care Med, 2008,34(4):720-727.
11 Park DW,Chun BC,Kim JM,et al.Epidemiological and clinical characteristics of community-acquired severe sepsis and septic shock:a prospective observational study in 12 university hospitals in Korea[J].J Korean Med Sci, 2012,27(11):1308-1314.
12 Tong DM,Zhou YT,Wang GS,et al.Early prediction and outcome of septic encephalopathy in acute stroke patients with nosocomial coma[J].J Clin Med Res,2015,7(7):534-539.
13 Mayr FB, Yende S, Linde-Zwirble WT,et al.Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis[J]. JAMA, 2010,303(24):2495-2503.
14 Lagu T, Rothberg MB, Shieh MS, et al.Hospitalizations,costs,and outcomes of severe sepsis in the United States 2003 to 2007[J].Crit Care Med, 2012,40(3):754-756.
15 Vincent JL,Rello J,Marshall J,et al.International study of the prevalence and outcomes of infection in intensive care units[J].JAMA,2009,302(3):2323-2329.
16 Bone RC, Grodzin CJ, Balk RA.Sepsis:a new hypothesis for pathogenesis of the disease process[J]. Chest,1997,112(12):235-243.
17 Boomer JS, To K, Chang KC,et al.Immunosuppression in patients who die of sepsis and multiple organ failure[J].JAMA,2011,306(23):2594-2605.
18 Hotchkiss RS, Tinsley KW, Swanson PE,et al.Depletion of dendritic cells,but not macrophages,in patients with sepsis[J]. J Immunol,2002,168(5):2493-2500.
19 Jackson AC,Gilbert JJ,Young GB,et al.The encephalopathy of sepsis[J].Can J Neurol Sci,1985,12(4):303-307.
20 del Zoppo G,Ginis I,Hallenbeck JM,et al.Inflammation and stroke:putative role for cytokines,adhesion molecules and iNOS in brain response to ischemia[J].Brain Pathol,2000,10(1):95-112.
21 Wang J.Preclinical and clinical research on inflammation after intracerebral hemorrhage[J].Prog Neurobiol, 2010,92(4):463-477.
22 Bone RC.Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome:what we do and do not know about cytokine regulation[J].Crit Care Med,1996,24(1):163-172.
23 Polito A,Eischwald F,Maho AL,et al.Pattern of brain injury in the acute setting of human septic stroke[J].Crit Care,2013,17(5):R204.
24 Sharshar T,Gray F,Poron F,et al.Multifocal necrutizing leukoencephalopathy in septic shock[J].Crit Care Med,2002,30(10):2371-2735.
25 Sharshar T,Annane D,de la Grandmaison GL,at el.The neuropathology of septic shock[J].Brain Pathol,2004,14(1):21-33.
26 Angus DC,Tomvander P.Severe sepsis and septic shock[J].N Engl J Med,2013,369(9):840-851.
27 Gofton TE,Young GB.Sepsis associated encephalopathy[J].Nat Rev Neurol, 2012,8(10):557-566.
28 Young GB,Bolton CF,Archibald YM,et al.The electroencephalogram in sepsis-associated encephalopathy[J].J Clin Neurophysiol,1992,9(1):145-152.
29 Sasse KC,Nauenberg E,Long A,et al.Long-term survival after intensive care unit admission with sepsis[J].Crit Care Med,1995,23(6):1040-1047.
30 Dellinger RP,Levy MM,Rhodes A,et al.Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup.Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock,2012[J].Intensive Care Med,2013,39(2):165-228.
31 Kelm DJ,Perrin JT,Cartin-Ceba R,et al.Fluid Overload in Patients with Severe Sepsis and Septic Shock Treated with Early-Goal Directed Therapy is Associated with Increased Acute Need for Fluid-Related Medical Interventions and Hospital Death[J].Shock,2015,43(1):68-73.
32 Rhen T,Cidlowski JA.Antiinflammatory action of glucocorticoids--new mechanisms for old drugs[J].N Engl J Med,2005,353(16):1711-1723.
33 Annane D, Bellissant E,Bollaert PE,et al.Corticosteroids in the treatment of severe sepsis and septic shock in adults:a systematic review[J].JAMA, 2009,301(22):2362-2375.
34 Barnes D,McDonald WI.A magnetic resonance imaging study of experimental cerebral edema and its response to dexamethasone[J]. Magn Reson Med,1988,7(1):125-131.
35 Rommel T,Bodsch W.Glucocorticosteroid treatment of vasogenic oedema[J].Acta Neurochir Suppl(Wien),1988,43:145-148.
36 李建国,李明泉,何新华.严重脓毒症/脓毒症休克与血液净化治疗[J].中华急诊医学杂志,2016,25(2):142-145.
37 Meisel C, Schefold JC, Pschowski R,et al.Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression:a double-blind,randomized,placebo-controlled multicenter trial[J]. Am J Respir Crit Care Med, 2009,180(7):640-648.
38 Docke WD, Randow F, Syrbe U,et al.Monocyte deactivation in septic patients:restoration by IFN-gamma treatment[J]. Nat Med, 1997,3(6):678-681.

(编辑:杨智华 收稿日期:2016-04-29)